Chapter 26: Narcotics, Narcotic Antagonists & Antimigraine Agents

The underlying physiological mechanisms of pain transmission are explored through the Gate Control Theory of Pain, which proposes that the ascending transmission of pain impulses—carried primarily by small-diameter A-delta and C nerve fibers—can be modulated or blocked (the "gate closed") by either descending inhibitory nerve pathways from higher central nervous system centers (which incorporate influences like learned experience and cultural factors) or by stimulation of large-diameter A fibers associated with sensations like touch. Narcotic agonists, derived historically from opium, achieve therapeutic effects such as analgesia, sedation, and euphoria by stimulating opioid receptors (specifically the mu and kappa receptors) found throughout the body. Mu-receptors primarily mediate pain blocking but also account for severe adverse effects like respiratory depression and the development of physical dependence, necessitating their classification as controlled substances. Narcotic agonists–antagonists (e.g., pentazocine) offer analgesic relief by stimulating some opioid receptors while simultaneously blocking others, generally resulting in a lower risk of dependence, though caution is required as they can precipitate a withdrawal syndrome in patients dependent on pure agonists. Essential for managing overdose, narcotic antagonists (e.g., naloxone) bind strongly to opioid receptors without activating them, rapidly reversing dangerous effects like respiratory depression and sedation, albeit potentially causing an acute narcotic abstinence syndrome. The chapter also details drugs for migraine headaches, which are severe, unilateral, throbbing pains linked to arterial dilation and hyperperfusion of cerebral vessels. Ergot derivatives (e.g., ergotamine) constrict both cranial and peripheral blood vessels, but their use is limited by potential adverse systemic vasoconstrictive effects, including ergotism. The newer class, triptans (e.g., sumatriptan), are selective serotonin receptor blockers that cause targeted cranial vasoconstriction to abort acute migraine attacks, and sumatriptan is uniquely approved for treating cluster headaches. Throughout all drug classes, nursing considerations emphasize patient safety, comprehensive pain assessment, meticulous dosage calculation (especially in pediatrics), recognition of potential drug–drug interactions, monitoring for organ impairment (renal/hepatic), and addressing cultural variations in pain perception and response.